0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Antiperistaltic Agents Contraindicated in Pseudomembranous Colitis

Saeed Ahmad, MD, MRCP
JAMA. 1980;243(10):1036. doi:10.1001/jama.1980.03300360012009.
Text Size: A A A
Published online

ABSTRACT

To the Editor.—  A recent report describing a fatal case of pseudomembranous colitis (242:749, 1979) warrants further comments. Antiperistaltic agents such as opiates and diphenoxylate hydrochloride with atropine sulfate (Lomotil) should not be used in pseudomembranous colitis, as these drugs prolong and worsen this condition by retarding the clearance of clostridial toxin in the stool.There are reports in the literature indicating a worse prognosis in patients with pseudomembranous colitis who are given the diphenoxylate and atropine mixture. I strongly believe that use of this drug had a bearing in the fatal outcome of the case in the aforementioned article.Finally, it should be stressed that there is no place for corticosteroids or corticotropin in the treatment of antibiotic-associated colitis. Because of the wide use of the mixture of diphenoxylate and atropine, heightened clinical awareness of its contraindication in pseudomembranous colitis is important.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();